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Figure S1. Both WT and pro-TLS mutant S990A correct defects in replication restart 
due to FANCJ deficiency. 
(A) Cell survival assays with U2OS FANCJ K/O cells complemented with FANCJWT (WT), 
empty vector (V) and the FANCJ-BRCA1 binding deficient, FANCJS990A (S990A) treated 
with increasing concentrations of MMC. Data represent the mean percent ± SD of survival 
from three independent experiments. 
(B) Western blot analysis with the indicated Abs of WCE from FANCJ null FA-J cells 
complemented with FANCJWT (WT), empty vector (V) and the FANCJ-BRCA1 binding 
deficient, FANCJS990A (S990A), the FANCJ helicase dead mutant (K52R) and the FANCJ- 
BRCA1 binding deficient and helicase dead (S990A+K52R) double mutant. 
(C) Experimental schematic and quantification of CldU (red) tract length either after 
treatment with 20uM TLSi alone or under unchallenged conditions as observed in the 
U2OS FANCJ K/O or FA-J complemented cells. 
(D) Experimental  schematic  and  the  quantification  of  CldU  (red)  tract  length  after 
co-incubation with 0.5mM HU or 2J/m2 of UV as observed in the FA-J complemented cells.  
(E) Experimental schematic and quantification of CldU (red) tract length, percent CldU 
(red) tract connected with IdU (green), percent only IdU (green) and percent only CldU 
(red) tract as observed in the FA-J complemented cells. 
(F) Experimental schematic and quantification of CldU (red) track length following 1h 
treatment with 0.5mM HU immediately followed by -/+ S1 nuclease treatment and as 
observed in the FA-J complemented cells. 
(G) Experimental schematic and quantification of CldU/IdU (red/green) ratio as observed 
in the FA-J complemented cells. 
(H) Cell survival assays with PEO1 cells expressing V5 tagged - empty vector (V), 
FANCJWT (WT), and the FANCJ-BRCA1 binding deficient, FANCJS990A (pro-TLS) under 
increasing concentrations of cisplatin. Data represent the mean percent ± SD of survival 
from three independent experiments. Experimental schematic and quantification of CldU 
(red) tract length after co-incubation with 0.5mM HU as observed in these cell lines. 
For every DNA fiber assay analysis, each dot represents one individual fiber. Experiments 
were performed in biological triplicate with at least 100 fibers per replicate. Bars represent 
the mean ± SD. Statistical analysis were performed according to two-tailed Mann-Whitney 
test. All p values are further described in the statistical methods. 
 
Figure S2. TLS polymerases overcome replication stress associated ssDNA gaps. 
(A-B) Representative images (63X) of eGFP-pol-eta (pol-η) or eGFP-Rev1 foci as 
observed in U2OS FANCJ K/O cells complemented with FANCJWT (WT) and the FANCJ-
BRCA1 binding deficient, FANCJS990A (S990A) and U2OS cells expressing shRNA against 
NSC or p21 transiently transfected with eGFP-pol-η or eGFP-Rev1 and assessed either 
after no treatment (Unt), post 4h 15J/m2 UV or post 48h 250nM MMC treatment. Around 
300 cells were counted from multiple fields. 
(C) Experimental schematic, representative images and quantification of the EdU (green) 
positive cells after varying doses of UV treatment as observed in U2OS FANCJ K/O cells 
complemented with FANCJWT (WT - Control) and the FANCJ-BRCA1 binding deficient, 
FANCJS990A (S990A – pro-TLS). EdU staining was performed as described in Figure 2  
(D-G) Experimental schematic, representative images and quantification of EdU (green) 
and ssDNA (red) positive cells following initial labeling with CldU for 48h followed by EdU 
treatment with or without 0.5mM HU -/+ 20µM TLSi or -/+ 5µM ATRi. EdU and ssDNA 
staining was performed as described in the Figure 2. 
Experiments were performed in biological triplicate. Bars represent the mean ± SD. 
Statistical analysis were performed according to two-tailed Mann-Whitney test. All p 
values are further described in the statistical methods. 
 
 
Figure S3. TLS polymerases counteract oncogene induced replication stress 
response. 
(A and C) Experimental schematic and representative images of EdU and ssDNA positive 
cells as previously described in Figure 3(B and E). 
(B) Representative images and quantification of the colony formation assay as observed 
in FANCJWT or FANCJS990A complemented FANCJ K/O U2OS cell lines stably infected 
with only vector (V) and as described in the Figure 3(C). 
Experiments were performed in biological triplicate. Bars represent the mean ± SD. 
Statistical analysis were performed according to two-tailed Mann-Whitney test. All p 
values are further described in the statistical methods.
 
Figure S4. TLS polymerase re-wiring of cancer cells promote unrestrained 
replication during stress. 
(A) Experimental schematic and quantification of EdU (green) positive cells. Cells were 
either labeled for 30mins with EdU or for 2h with EdU and varying doses of HU. Cells were 
stained for EdU as previously described in Figure 2. Percent EdU positive cells were 
quantified from around 300 cells counted from multiple fields. 
(B) Experimental schematic and quantification of EdU (green) and ssDNA (red) positive 
cells as previously described in Figure 4(A). 
Experiments were performed in biological triplicate. Bars represent the mean ± SD. 
Statistical analysis were performed according to two-tailed Mann-Whitney test. All p values 
are further described in the statistical methods. 
 
 
Figure S5. FANCJ promotes TLS pathway by suppressing the negative regulator, 
p21 
(A) Western blot analysis with the indicated Abs of WCE from HeLa CRISPR control and 
FANCJ CRISPR knockout (K/O) cells and HeLa FANCJ K/O cells expressing shRNA 
against NSC or p21. Experimental schematic and quantification of EdU (green) positive 
cells. Cells were either labeled for 30mins with EdU or 2h with EdU and 0.5mM HU. Cells 
were stained for EdU as previously described in Figure 2. 
(B and D) Representative images and quantification of the colony formation assay as 
observed in HeLa CRISPR control and FANCJ CRISPR knockout (K/O) cells and HeLa 
FANCJ K/O cells expressing shRNA against NSC or p21. The HeLa FANCJ K/O shRNA 
p21 cells were either grown in absence or continuous presence of 20µM TLSi. 
(C) Experimental schematic and quantification of EdU (green) and ssDNA (red) positive 
cells as previously described in Figure 4(A). EdU and ssDNA was staining performed as 
described in Figure 2. 
Experiments were performed in biological triplicate. Bars represent the mean ± SD. 
Statistical analysis were performed according to two-tailed Mann-Whitney test. All p values 
are further described in the statistical method.
Figure S6. TLSi as a promising cancer therapy (A-D) Representative images and 
quantification of the colony formation assay after dose dependent treatment with ATRi (µM) 
and WEE1i (nM) alone or in combination with 20µM TLSi across different cell lines. 
Experiments were performed in biological triplicate. Bars represent the mean ± SD. 
Statistical analysis were performed according to two-tailed Mann-Whitney test. All p values 
are further described in the statistical methods. 
 









